Article Details

AstraZeneca Gets CDSCO Panel Nod for Enhertu 100mg for additional indication of breast cancer

Retrieved on: 2023-12-25 17:56:08

Tags for this article:

Click the tags to see associated articles and topics

AstraZeneca Gets CDSCO Panel Nod for Enhertu 100mg for additional indication of breast cancer. View article details on HISWAI: https://medicaldialogues.in/news/industry/pharma/astrazeneca-gets-cdsco-panel-nod-for-enhertu-100mg-for-additional-indication-of-breast-cancer-122115

Excerpt

New Delhi: Noting an unmet medical need in the country, the Subject Expert Committee (SEC) functional under the Central Drug Standard Control ...

Article found on: medicaldialogues.in

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up